| |
| |
|
| Insider
Information: |
Given Douglas B |
| Relationship: |
Director |
| City: |
Lincolnshire |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
129,711 |
|
|
Indirect Shares
|
148,367 |
|
|
| Direct
Value |
$2,869,207 |
|
|
|
Indirect Value
|
$564,060 |
|
|
| Total
Shares |
278,078 |
|
|
| Total
Value |
$3,433,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
10
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -47.6%
|
-107.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corautus Genetics Inc |
VEGF |
Director |
2007-06-05 |
0 |
2007-06-05 |
122,867 |
Premium* |
|
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Director |
2024-01-11 |
129,711 |
2023-05-05 |
25,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2024-01-11 |
4 |
AS |
$37.76 |
$110,788 |
D/D |
(2,911) |
129,711 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-12-15 |
4 |
A |
$25.41 |
$380,820 |
D/D |
14,987 |
132,622 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-05-05 |
4 |
S |
$40.90 |
$265,850 |
D/D |
(6,500) |
117,635 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-02-27 |
4 |
S |
$32.62 |
$28,543 |
I/I |
(875) |
13,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,867 |
124,135 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,400 |
116,268 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-12-28 |
4 |
B |
$66.37 |
$43,472 |
D/D |
655 |
109,868 |
2.39 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
655 |
109,213 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-09-09 |
4 |
S |
$65.24 |
$326,200 |
D/D |
(5,000) |
109,868 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-06-22 |
4 |
S |
$89.21 |
$401,445 |
D/D |
(4,500) |
114,868 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-02-22 |
4 |
S |
$88.73 |
$99,821 |
I/I |
(1,125) |
13,875 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-15 |
4 |
S |
$83.28 |
$249,840 |
I/I |
(3,000) |
12,500 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
S |
$76.08 |
$304,320 |
D/D |
(4,000) |
119,368 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
123,368 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
35 |
113,868 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
235 |
113,903 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-17 |
4 |
S |
$79.30 |
$719,648 |
D/D |
(9,075) |
114,738 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-17 |
4 |
S |
$79.59 |
$39,795 |
I/I |
(500) |
15,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
114,138 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
31,000 |
15,500 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
31,000 |
123,813 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-04-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,112 |
154,813 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-04-14 |
4 |
S |
$36.89 |
$922,250 |
D/D |
(25,000) |
155,925 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
180,925 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2019-02-26 |
4 |
AS |
$19.25 |
$1,251,250 |
D/D |
(65,000) |
175,130 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
